Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 50% Gains Investing -- Ignore unavailable to you. Want to Upgrade?

To: Dale Baker who wrote (24981)	4/30/2001 8:36:00 AM
From: Henrik	Respond to of 118717

Anyone contemplating following Dale into the world of PGLAF should take time to read about this Brisbane, Queensland, Australia based medical research company. Progen Industries Limited is a biotechnology company committed to the discovery, development and commercialization of small molecule pharmaceuticals for the treatment of a variety of diseases for which there is a significant demand for new therapies. Our drug discovery efforts are focused on the development of potent, selective inhibitors of carbohydrate-protein interactions. These molecular interactions are implicated in a range of different diseases. A new web site was released only earlier today: progen.com.au There is a thread where I post news as it is announced on ASX : Subject 26617 Also worth knowing is that Progen is a significant shareholder (~19%) in Zaxis International (BB:ZAXSE). Zaxis Inc. develops, manufacturers and markets high performance products used to detect and separate various proteins and nucleic acids. ZAXIS web site : zaxis-inc.com ZAXIS largest customer is VISIBLE GENETICS (Nasdaq NM:VGIN) VGIN is very close to FDA approval - expected in May. Visible Genetics Inc. develops, manufactures and sells integrated DNA sequencing systems that analyze genetic information to improve the treatment of selected diseases. Yahoo: biz.yahoo.com VGIN web site: visiblegenetics.com Bottom line - if VGIN is successful ZAXSE should do well and this in turn would be an added bonus for PGLAF. Disclosure : I have positions in PGLAF, ZAXSE & VGIN.

To: Dale Baker who wrote (24981)	4/30/2001 11:37:52 AM
From: Jibacoa	Read Replies (1) \| Respond to of 118717

PGLAF: It had a nice move last week. I mentioned it on the Biotech Valuation thread: Message 15727436 At the time I said: "This is a "penny stock" that a few weeks ago announced the Univ.Hospital in Tapei was going to start a Phase Ib on their anti-angoiogenesis product. <g> Institutions reportedly have been buying lately, I haven't as yet.<g>" Since then, and after looking at the chart, I decided to buy some, so am I glad to read your comment about it. Bernard